Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults

We conducted a nonrandomized, open-label phase I study to assess the safety and immunogenicity of an intradermal coronavirus disease 2019 (COVID-19) DNA vaccine (AG0302-COVID-19) administered using a pyro-drive jet injector at Osaka University Hospital between Yanagida November 2020 and December 202...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagami, Hironori, Hayashi, Hiroki, Sun, Jiao, Yanagida, Yuka, Otera, Takako, Nakagami, Futoshi, Hamaguchi, Shigeto, Yoshida, Hisao, Okuno, Hideo, Yoshida, Shota, Nakamaru, Ryo, Yokoyama, Serina, Fujimoto, Taku, Hongyo, Kazuhiro, Akeda, Yukihiro, Morishita, Ryuichi, Tomono, Kazunori, Rakugi, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503587/
https://www.ncbi.nlm.nih.gov/pubmed/36146505
http://dx.doi.org/10.3390/vaccines10091427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503587/
https://www.ncbi.nlm.nih.gov/pubmed/36146505
http://dx.doi.org/10.3390/vaccines10091427

Ejemplares similares